Nataliya Uboha, MD
Enriched profileAssociate Professor, Division of Hematology, Medical Oncology, and Palliative Care · University of Wisconsin School of Medicine and Public Health
Nataliya Uboha is Associate Professor, Division of Hematology, Medical Oncology, and Palliative Care at University of Wisconsin School of Medicine and Public Health. OpenAlex indexes 300 publications with 1,826 citations (h-index 19); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 17 Oct 2026
Overview
Updated 18 Oct 2026
Nataliya Uboha, MD, is Associate Professor, Division of Hematology, Medical Oncology, and Palliative Care at University of Wisconsin School of Medicine and Public Health, Division of Hematology, Medical Oncology, and Palliative Care; University of Wisconsin Carbone Cancer Center. The public record shows 300 publications with 1,826 citations (h-index 19), centered on Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Colorectal Cancer Surgical Treatments. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 19 companies.
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Colorectal Cancer Treatments and Studies
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 34.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Sponsor: ECOG-ACRIN Cancer Research Group
- Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 18 Oct 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20259 payments
- Gilead Sciences, Inc.Program year20252 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.5%Serotonin-3 Receptor Antagonist21.4%Ondansetron Hcl100%Part D≥47 patientsH2 blocker7.2%Famotidine100%Part D≥15 patients+ 3 more classes in this area
Nervous system
21.7%Phenothiazine8.7%Prochlorperazine Maleate100%Part D≥24 patientsOpioid Agonist5.8%Oxycodone Hcl100%Part D≥13 patients+ 2 more classes in this area
Sensory organs
21.1%Corticosteroid21.1%Dexamethasone100%Part D≥39 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 18 Oct 2026
75 congress contributions (2017–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 2507: Causal machine learning personalizes endocrine therapy selection for ductal carcinoma in situ
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.
Journal of clinical oncology
Guideline2026 - Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.
Nature medicine
Clinical Trial2026 - The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).
Cancer research communications
Clinical Trial2025 - Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.
Journal of surgical oncology
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyArticle215 citations2025
- 03Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO GuidelineArticle215 citations2023
- 04
- 05Esophagogastric Cancers: Integrating Immunotherapy Therapy Into Current PracticeArticle76 citations2022
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nataliya-uboha-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/nataliya-uboha-8b817484
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
med.wisc.edu/news/nataliya-uboha-named-ctd2-leader
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.wisc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Yale University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - PhD in Molecular Neuroscience
Yale University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Internal Medicine Residency
Yale New Haven Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Medical Hematology and Oncology Fellowship
Smilow Cancer Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
- Chair
ECOG-ACRIN Upper GI Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Co-Chair
National Cancer Institute Upper GI Taskforce
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Member
NCCN Guidelines Committee for Esophageal and Gastric Cancers
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Secondary affiliations
appointments beyond the home institution- Co-director
Wisconsin Oncology Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.wisc.edu ↗ - Faculty Leader
Early Phase Oncology Therapeutics Program (EPOT), University of Wisconsin Carbone Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Nasia Safdar, MD
University of Wisconsin School of Medicine and Public Health
Dustin Deming, MD
University of Wisconsin School of Medicine and Public Health
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH